Xu LX - Search Results

1

Neutrophils promote the activation of monocytes via ROS to boost systemic antitumor immunity after cryo-thermal therapy.

Wang S, Zhang Z, Wang J, Lou Y, Zhu Y, You J, Liu P, Xu LX. Wang S, et al. Among authors: xu lx. Front Immunol. 2024 Nov 1;15:1445513. doi: 10.3389/fimmu.2024.1445513. eCollection 2024. Front Immunol. 2024. PMID: 39555061 Free PMC article.

2

Cryo-thermal therapy reshaped the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy.

Wang S, Peng P, Wang J, Zhang Z, Liu P, Xu LX. Wang S, et al. Among authors: xu lx. Cancer Immunol Immunother. 2024 Nov 13;74(1):21. doi: 10.1007/s00262-024-03884-2. Cancer Immunol Immunother. 2024. PMID: 39535552 Free PMC article.

3

Prediction of dialysis adequacy using data-driven machine learning algorithms.

Liu YC, Qing JP, Li R, Chang J, Xu LX. Liu YC, et al. Among authors: xu lx. Ren Fail. 2024 Dec;46(2):2420826. doi: 10.1080/0886022X.2024.2420826. Epub 2024 Nov 11. Ren Fail. 2024. PMID: 39526333 Free PMC article.

4

A Dual-Band Patch Antenna with Combined Self-Decoupling and Filtering Properties and Its Application in Dual/Squad-Band Two-Element MIMO Array.

Lv JY, Zhang JM, Lv PF, Xu LX. Lv JY, et al. Among authors: xu lx. Sensors (Basel). 2024 Oct 24;24(21):6833. doi: 10.3390/s24216833. Sensors (Basel). 2024. PMID: 39517729 Free PMC article.

5

Longitudinal and time-to-event modeling for the survival of advanced pancreatic ductal adenocarcinoma patients.

Yao QY, Luo PY, Xu LX, Chen R, Xue JS, Yong L, Shen L, Zhou J, Zhou TY. Yao QY, et al. Among authors: xu lx. Acta Pharmacol Sin. 2024 Oct 21. doi: 10.1038/s41401-024-01403-8. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 39433717

6

Increased CRHR1 expression on monocytes from patients with AA enables a pro-inflammatory response to corticotrophin-releasing hormone.

Guo HW, Lai HJ, Long BQ, Xu LX, Wang EHC, Shapiro J, McElwee KJ. Guo HW, et al. Among authors: xu lx. Exp Dermatol. 2024 Oct;33(10):e15182. doi: 10.1111/exd.15182. Exp Dermatol. 2024. PMID: 39367575

7

Nab-paclitaxel plus capecitabine as first-line treatment for advanced biliary tract cancers: An open-label, non-randomized, phase II clinical trial.

Xu LX, Yuan JJ, Xue R, Zhou J. Xu LX, et al. World J Gastroenterol. 2024 Aug 14;30(30):3564-3573. doi: 10.3748/wjg.v30.i30.3564. World J Gastroenterol. 2024. PMID: 39193574 Free PMC article. Clinical Trial.

8

Comparative study of the clinical value of digital subtraction angiography via femoral and radial arterial paths.

Zeng H, Xie JY, Xu LX, Cao WY, Liu MJ, Que SW. Zeng H, et al. Among authors: xu lx. Am J Transl Res. 2024 Jul 15;16(7):3064-3071. doi: 10.62347/UBEV9768. eCollection 2024. Am J Transl Res. 2024. PMID: 39114697 Free PMC article.

9

Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study.

Lv J, Xu LX, Li ZX, Lin L, Wu CF, Quan TQ, Zhen ZC, Li WF, Tang LL, Mao YP, Chen L, Guo R, Zhang LL, Ai XL, Wu SY, Hao MY, Wei D, Li JB, Ma J, Chen YP, Zhou GQ, Sun Y. Lv J, et al. Among authors: xu lx. Cancer Cell. 2024 Aug 12;42(8):1401-1414.e4. doi: 10.1016/j.ccell.2024.07.001. Epub 2024 Jul 25. Cancer Cell. 2024. PMID: 39059389 Free article.

10

Zinc finger BED-type containing 3 promotes hepatic steatosis by interacting with polypyrimidine tract-binding protein 1.

Wu Y, Yang M, Wu SB, Luo PQ, Zhang C, Ruan CS, Cui W, Zhao QR, Chen LX, Meng JJ, Song Q, Zhang WJ, Pei QQ, Li F, Zeng T, Du HX, Xu LX, Zhang W, Zhang XX, Luo XH. Wu Y, et al. Among authors: xu lx. Diabetologia. 2024 Oct;67(10):2346-2366. doi: 10.1007/s00125-024-06224-2. Epub 2024 Jul 22. Diabetologia. 2024. PMID: 39037604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters